Novel findings in drug-induced dendritic cell tolerogenicity (Q37809070)

23 August 2017

Novel findings in drug-induced dendritic cell tolerogenicity (English)

1 reference

23 August 2017

1 reference

Urban Svajger

1

1 reference

PubMed ID

21073328

23 August 2017

Nataša Obermajer

series ordinal

2

1 reference

PubMed ID

21073328

23 August 2017

Matjaž Jeras

series ordinal

3

1 reference

23 August 2017

1 December 2010

1 reference

International Reviews of Immunology

23 August 2017

1 reference

23 August 2017

29

1 reference

23 August 2017

6

1 reference

23 August 2017

574-607

1 reference

Tolerogenic dendritic cells

23 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Tolerogenic dendritic cells: cytokine modulation comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Outer membrane protein A expression in Escherichia coli K1 is required to prevent the maturation of myeloid dendritic cells and the induction of IL-10 and TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Dendritic cells: emerging pharmacological targets of immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

LF15-0195 generates tolerogenic dendritic cells by suppression of NF-kappaB signaling through inhibition of IKK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Rapamycin impairs antigen uptake of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

An overview on biological mechanisms of PPARs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Adenosine release from stimulated mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Triptolide affects the differentiation, maturation and function of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Transient receptor potential vanilloid-1 signaling inhibits differentiation and activation of human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Effects of triterpenes on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Epigallocatechin gallate affects human dendritic cell differentiation and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: involvement of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Tumor necrosis factor receptor and Fas signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

ASK1 is essential for JNK/SAPK activation by TRAF2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-alpha-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Inhibition of T cell proliferation by macrophage tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The tryptophan photoproduct 6-formylindolo[3,2-b]carbazole (FICZ) binds multiple AHRs and induces multiple CYP1 genes via AHR2 in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Monocytes give rise to mucosal, but not splenic, conventional dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Leflunomide: mode of action in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1beta stimulated rheumatoid synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Coordinated ATP hydrolysis by the Hsp90 dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The effects of phenolic components of tea on the production of pro- and anti-inflammatory cytokines by human leukocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Radical scavenging by flavonoid antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Green tea and skin--anticarcinogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Molecular basis for cancer chemoprevention by green tea polyphenol EGCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Interleukin-21 inhibits dendritic cell activation and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The IKK NF-kappa B system: a treasure trove for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Resveratrol: its biologic targets and functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Resveratrol is a class IA phosphoinositide 3-kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Non-carbohydrate inhibitors of the lectin DC-SIGN.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Self- and nonself-recognition by C-type lectins on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Immunomodulatory and pharmacologic properties of imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Imiquimod inhibits the differentiation but enhances the maturation of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Development of dendritic cell-based immunotherapy for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Dendritic cell-based therapy in Type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.522280

10.3109/08830185.2010.522280

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21073328